James Hattersley

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.